June 12, 2021
On June 7, the FDA granted accelerated approval for aducanumab (Aduhelm), the first drug approved to treat Alzheimer’s disease since 2003. However, there is limited evidence that this treatment will slow progression of this devastating disease. Learn all you need to know in our FAQ.